Recent Advances in the Treatment of Patients with Multiple Myeloma

Cancers

MaríaJ. Cejalvo¹  MarioA. Legarda¹  Javier de la Rubia¹ 

[1] Hematology Department, University Hospital Doctor Peset, 46017 Valencia, Spain;

关键词: multiple myeloma;    autologous stem cell transplantation;    consolidation;    maintenance;    relapsed refractory multiple myeloma;    early relapse;   

DOI  :  10.3390/cancers12123576

来源: DOAJ

【 摘 要 】

In the past 20 years, few diseases have seen as great progress in their treatment as multiple myeloma. With the approval of many new drugs and the limited availability of clinical trials comparing head-to-head the different possible combinations, the choice of the best treatments at each stage of the disease becomes complex as well as crucial since multiple myeloma remains incurable. This article presents a general description of the novelties of the whole treatment of multiple myeloma, from induction in the newly diagnosed patient through the role of hematopoietic stem cell transplantation and maintenance treatment until early and late relapses, including a section on recently approved drugs as well as novel drugs and immunotherapy in advanced stages of research, and that will surely play a relevant role in the treatment of this devastating disease in the coming years.

【 授权许可】

Unknown